Home

Europe has a deep tech scaling problem and here’s why

Share This Post

Reading Time: 3 minutes

Industry buzz:

Here is what caught our attention over the past few weeks.

Portfolio Highlights

FitBiomics (requires registration to view), a startup that uses microbiome technology to help improve athlete performance, recently partnered with the San Francisco Marathon on their first product Nella, a performance probiotic geared specifically toward people with active lifestyles. Endurance Sportswire News

Myolyn (requires registration to view), a medical device startup that provides mobility solutions to people with disability, received 510(k) clearance from the Food and Drug Administration (FDA) for the new, second version of their flagship rehabilitation product, the MyoCycle. Cision PR Web News

These links are provided solely as a convenience to readers and they do not imply an affiliation, sponsorship, endorsement, approval, investigation, verification, or monitoring by Hubble Investments or any of its affiliates of the contents on such third-party websites.

Propel(x) in Media

Reviewed by Benzinga – Financial News & Analysis Service Provider

Read more →

Disclosure: This is a sponsored review and contains links from our affiliate partners.

Upcoming Roundtable Event : Visionary Women in Venture Capital

Join our co-founder and CEO, Swati Chaturvedi in a roundtable discussion with other experts from the venture capital industry as they discuss the alternative investment landscape and potential trends for different sectors in 2022 and beyond. Moderated by Charlene Yu Vaughn – CEO, The Algonquin Group and John Park – Partner, Morgan Lewis, speakers include Trish Costello from Portfolia and Elana Lian from Intel Capital.

Note: This meeting is for informational purposes only. It is not a solicitation or offer to purchase or sell any security, nor should this information be construed as advice for investment decisions.

More about the session →

Bring Your Own Deal (BYOD)

If you have pro-rata in a growth stage round (Series B, C), and you are not able to fill it, please share it with Propel(x). We routinely invest in pro-rata opportunities for VCs and angel investors via our syndicates. In exchange, we share up to half the carried interest that we will receive on our syndicates.

Questions? Contact us

What is a hedge fund and how to invest in one?

Hedge funds got their name from the original “Long-Short Equity” strategy, which was adopted to try to minimize downside risk by taking short positions in stocks that are expected to decrease in value to balance long positions taken in stocks that are expected to increase in value.

We are talking about hedge funds not only because we believe it is important for investors to have a broad understanding of potential investment opportunities that are available in the marketplace but also because Propel(x) is planning to provide access for qualified Propel(x) members to invest in a hedge fund with small check sizes via a syndicate using a Special Purpose Vehicle. We will release additional information on this opportunity as it becomes available.

Continue reading →

From the Archives

A three part primer on convertible note, equity and startup investing.

  1. Preferred Stock vs. Common Stock in Startups
  2. What is a Convertible Preferred Stock and how does it work?
  3. What is a Convertible Note and how does it work?

 

.    .    .

Disclaimer: Articles or information from third-party sources outside of this domain may discuss Propel(x) or relate to information contained herein, but Propel(x) does not approve and is not responsible for such content. Hyperlinks to third-party sites, or reproduction of third-party content, do not constitute an approval or endorsement by Propel(x) or Hubble Investments, Propel(x)’ broker-dealer affiliate, of the linked or reproduced content.

Private Placements are a high-risk investment. An investment in such offerings is speculative and an investor could experience an entire loss of principal. Past performance may not be indicative of future results. Private investments are highly illiquid and risky and are not suitable for all investors. Investments in early-stage private companies should only be part of your overall investment portfolio.

Information provided in this article is not intended to be nor should it be construed or used as, investment, tax, or legal advice, a recommendation, an offer to sell, or a solicitation of an offer to buy, an interest, directly or indirectly, in any company.

Do you like this edition?

Newsletter

Get our blogs delivered to your inbox!

Start Investing Today​